Javelin Biotech
Woburn
About Javelin Biotech
Javelin Biotech is a framework for predictive drug discovery designed to improve drug performance prediction in humans. The company's platform enables biopharmaceutical companies to optimize ADME(T) and PD properties, which improve drug discovery and approval of the same, by bringing human-relevant in-vitro data and computational biology or data analytics to pre-clinical drug discovery teams. This accelerates preclinical drug discovery and development by finding human-relevant targets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Pre-Seed (Jan 2019)
- Website: javelinbiotech.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/javelin-biotech-2231165 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.